P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study

BACKGROUND Preclinical studies suggest that P2X3 receptors are expressed by airway vagal afferent nerves and contribute to the hypersensitisation of sensory neurons. P2X3 receptors could mediate sensitisation of the cough reflex, leading to chronic cough. We aimed to investigate the efficacy of a first-in-class oral P2X3 antagonist, AF-219, to reduce cough frequency in patients with refractory chronic cough. METHODS We did a double-blind, placebo-controlled, two-period, crossover study at one UK centre. With a computer-generated sequence, we randomly assigned patients with refractory chronic cough to AF-219, 600 mg twice a day, or to placebo (1:1), and then, after a 2 week washout, assigned patients to receive the other treatment. Patients, health-care providers, and investigators were masked to sequence assignment. We assessed daytime cough frequency (primary endpoint) at baseline and after 2 weeks of treatment using 24 h ambulatory cough recordings. The primary analysis used a mixed effects model with the intention-to-treat population. This study was registered at ClinicalTrials.gov, number NCT01432730. FINDINGS Of 34 individuals assessed between Sept 22, 2011, and Nov 29, 2012, we randomly assigned 24 patients (mean age 54·5 years; SD 11·1). In the observed case analysis, cough frequency was reduced by 75% when patients were allocated to AF-219 compared when allocated to placebo (p=0·0003). Daytime cough frequency fell from a mean 37 coughs per h (SD 32) to 11 (8) coughs per h after AF-219 treatment versus 65 (163) coughs per h to 44 (51) coughs per h after placebo. Six patients withdrew before the end of the study because of taste disturbances, which were reported by all patients taking AF-219. INTERPRETATION P2X3 receptors seem to have a key role in mediation of cough neuronal hypersensitivity. Antagonists of P2X3 receptors such as AF-219 are a promising new group of antitussives. FUNDING Afferent Pharmaceuticals.

[1]  I. Pavord,et al.  Recommendations for the management of cough in adults , 2006, Thorax.

[2]  O. Usmani,et al.  Chronic idiopathic cough: a discrete clinical entity? , 2005, Chest.

[3]  S. Birring,et al.  Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial , 2012, The Lancet.

[4]  H. Koskela,et al.  Hypertonic saline cough provocation test with salbutamol pre‐treatment: evidence for sensorineural dysfunction in asthma , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[5]  A. Ford,et al.  A role for ATP in bronchoconstriction‐induced activation of guinea pig vagal intrapulmonary C‐fibres , 2012, The Journal of physiology.

[6]  B. Khakh,et al.  P2X receptors as cell-surface ATP sensors in health and disease , 2006, Nature.

[7]  J. Kamei,et al.  Involvement of P2X receptor subtypes in ATP-induced enhancement of the cough reflex sensitivity. , 2005, European journal of pharmacology.

[8]  G. Burnstock,et al.  Purinergic Signaling in the Airways , 2012, Pharmacological Reviews.

[9]  L. McGarvey,et al.  Are there clinical features of a sensitized cough reflex? , 2009, Pulmonary pharmacology & therapeutics.

[10]  Geoffrey Burnstock,et al.  Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X 3-deficient mice , 2000, Nature.

[11]  R. North,et al.  Immunohistochemical study of the P2X2 and P2X3 receptor subunits in rat and monkey sensory neurons and their central terminals , 1997, Neuropharmacology.

[12]  J. Smith,et al.  Pharmacodynamic modeling of cough responses to capsaicin inhalation calls into question the utility of the C5 end point. , 2013, The Journal of allergy and clinical immunology.

[13]  G. Burnstock,et al.  Localization of ATP-gated P2X2 and P2X3 receptor immunoreactive nerves in rat taste buds. , 1999, Neuroreport.

[14]  D. Forman,et al.  Cough in the community: a cross sectional survey and the relationship to gastrointestinal symptoms , 2006, Thorax.

[15]  J. Kamei,et al.  Involvement of ionotropic purinergic receptors in the histamine-induced enhancement of the cough reflex sensitivity in guinea pigs. , 2006, European journal of pharmacology.

[16]  S. Birring,et al.  Antitussive Drugs—Past, Present, and Future , 2014, Pharmacological Reviews.

[17]  M. P. Dillon,et al.  Pharmadynamic (PD) & pharmacokinetic (PK) properties of AF‐219: first in class, selective, clinical P2X3 antagonist in development for chronic pain and related conditions , 2013 .

[18]  S. Subburaj,et al.  Application and validation of a computerized cough acquisition system for objective monitoring of acute cough: a meta-analysis. , 2001, Chest.

[19]  Kevin McGuinness,et al.  P159 Validation of the VitaloJAK™ 24 Hour Ambulatory Cough Monitor , 2012, Thorax.

[20]  P. Barnes,et al.  Effects of aerosolized adenosine 5'-triphosphate vs adenosine 5'-monophosphate on dyspnea and airway caliber in healthy nonsmokers and patients with asthma. , 2005, Chest.

[21]  Christopher E Brightling,et al.  The utility of the mannitol challenge in the assessment of chronic cough: a pilot study , 2008, Cough.

[22]  Kevin McGuinness,et al.  Chronic cough: how do cough reflex sensitivity and subjective assessments correlate with objective cough counts during ambulatory monitoring? , 2007, Thorax.

[23]  L. Boulet,et al.  Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. , 2006, Chest.

[24]  K. Kwong,et al.  P2X2 receptors differentiate placodal vs. neural crest C-fiber phenotypes innervating guinea pig lungs and esophagus. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[25]  B. Canning,et al.  Cough sensors. I. Physiological and pharmacological properties of the afferent nerves regulating cough. , 2009, Handbook of experimental pharmacology.

[26]  S. Schappert,et al.  Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1997. , 1997, Vital and health statistics. Series 13, Data from the National Health Survey.

[27]  T. Finger,et al.  ATP Signaling Is Crucial for Communication from Taste Buds to Gustatory Nerves , 2005, Science.

[28]  K. Fletcher,et al.  Evaluation of a cough-specific quality-of-life questionnaire. , 2002, Chest.

[29]  A. Morice,et al.  Opiate therapy in chronic cough. , 2007, American journal of respiratory and critical care medicine.

[30]  K. Horton,et al.  Thalidomide for the Treatment of Cough in Idiopathic Pulmonary Fibrosis , 2012, Annals of Internal Medicine.

[31]  I. Pavord,et al.  Prevalence, pathogenesis, and causes of chronic cough , 2008, The Lancet.

[32]  R. Pellegrino,et al.  Lung mechanics during induced bronchoconstriction. , 1996, Journal of applied physiology.

[33]  A. Woodcock,et al.  The effect of mindfulness meditation on cough reflex sensitivity , 2009, Thorax.

[34]  C. Parada,et al.  Neuronal P2X3 receptor activation is essential to the hyperalgesia induced by prostaglandins and sympathomimetic amines released during inflammation , 2013, Neuropharmacology.